The present invention provides methods of making determinations regarding the state of cognition within a subject by determining whether a plurality of miRNAs has deregulated biological expression in a sample from the subject. The present invention also provides methods of making determinations regarding the potential severity of pathologies associated with neurodegenerative disorders by determining whether a plurality of miRNAs has deregulated biological expression in a sample from the subject.
METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF NEURODEGENERATIVE DISEASES